Article Text

Download PDFPDF
Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study
  1. Hirokazu Usui, MD, PhD,
  2. Jia Qu, MD, PhD,
  3. Asuka Sato, MD,
  4. Zijun Pan, MD,
  5. Akira Mitsuhashi, MD, PhD,
  6. Hideo Matsui, MD, PhD and
  7. Makio Shozu, MD, PhD
  1. Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  1. Address correspondence and reprint requests to Hirokazu Usui, MD, PhD, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail: hirokazu-usui{at}faculty.chiba-u.jp.

Abstract

Objective The aim of this study was to evaluate the incidence and risk factors of gestational trophoblastic neoplasia (GTN) from hydatidiform moles (HMs) cytogenetically diagnosed in a prospective cohort setting.

Methods The prospective observational cohort study included cases of cytogenetically defined molar pregnancies, which were diagnosed by a multiplex short tandem repeat polymorphism analysis. Cases were classified as androgenetic complete HMs (CHMs), diandric monogynic triploid partial HMs (PHMs), or biparental abortion. Gestational trophoblastic neoplasia was diagnosed according to the International Federation of Gynecology and Obstetrics 2000 criteria. Incidences for each category, that is, CHM, PHMs, and biparental abortion, were calculated. Clinical variables (age, partner age, gravidity, parity, height, weight, BMI, and gestational age) and laboratory data (serum human chorionic gonadotropin [hCG], white blood cell count, hemoglobin, and platelet count) were compared between spontaneous remission cases and GTN cases in androgenetic CHMs.

Results Among 401 cases, 380 were classified as follows: 232 androgenetic CHMs, 60 diandric monogynic PHMs, and 88 biparental abortions. A total of 35 cases (15.1%) of CHMs, but only 1 case of PHM (1.7%) and no biparental abortions, exhibited progression to GTN. The hCG value before evacuation was significantly higher in GTN cases than in spontaneous remission cases (P = 0.001, Kruskal-Wallis test). Patient age was also significantly higher in GTN cases than in spontaneous remission cases (P = 0.002, Student t test).

Conclusions Under the cohort cytogenetic diagnosis setting, the traditional risk factors for GTN after molar pregnancy, hCG value before evacuation and age, were confirmed in androgenetic CHMs. The risk of GTN was lower for PHMs than for CHMs. However, 1 patient with cytogenetic PHMs developed into GTN.

  • Gestational trophoblastic neoplasia
  • Human chorionic gonadotropin
  • Hydatidiform mole
  • Short tandem repeat polymorphism analysis

Statistics from Altmetric.com

Footnotes

  • H.M. is now with the Department of Obstetrics & Gynecology, Funabashi Futawa Hospital, Chiba, Japan.

  • This work was partially supported by JSPS KAKENHI grants JP23592435 and JP15K10703 (to H.U.) and grant JP25253092 (to M.S.). J.Q. was a scholar of the Otsuka Toshimi Scholarship Foundation.

  • The authors declare no conflicts of interest.

  • Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.ijgc.net).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.